Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Indiana · 2026 Regular Session · Bill

SB 150: Insulin price cap.

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 150 is a bill introduced in the Indiana Senate on January 5, 2026. According to its official title, it concerns: Insulin price cap. Primary sponsor: Rodney Pol (Democratic). Most recent recorded action (January 5, 2026): First reading: referred to Committee on Health and Provider Services.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Requires an insurer to cap the total amount an insured is required to pay for a 30 day supply of prescription insulin drugs at an amount not to exceed $35, regardless of the number of prescriptions and different types of insulin prescribed and filled during that period.

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Rodney PolPrimary sponsorDemocraticSenate4

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. First reading: referred to Committee on Health and Provider Services
  2. Authored by Senator Pol

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source